1-3 of 3
Imogen R Caldwell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Utility of High-Throughput Sequencing of Immunoglobulin Genes for MRD in Lymphoid Malignancy in the Context of Current Immunotherapeutics

Imogen R Caldwell, Michael Ingbritsen, Yan Zhuang Yap, Mark R Dowling, Ing S Tiong, David A Westerman, Piers Blombery
Journal: Blood
Blood (2022) 140 (Supplement 1): 10731–10732.
https://doi.org/10.1182/blood-2022-162228
Published: 2022
Journal Articles

Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma, Including Those with TP53 Mutated and Btki-Refractory Disease: First Report of the Tarmac Study

Adrian Minson, Nada Hamad, Chan Y. Cheah, Constantine S. Tam, Piers Blombery, David A Westerman, Stephen Lade, David Ritchie, Rachel M Koldej, Mary Ann Anderson, Amit Khot, John F. Seymour, Molly Robertson, Imogen R Caldwell, Georgina L Ryland, Jing Xie, Huw Morgan, Michael Dickinson
Journal: Blood
Blood (2022) 140 (Supplement 1): 181–183.
https://doi.org/10.1182/blood-2022-160459
Published: 2022
Journal Articles

Novel Non-Coding, Coding and Structural Variants in Hairy Cell Leukemia from Whole Genome Transcriptome Sequencing

Piers Blombery, Wencke Walter, Stephan Hutter, Constance Baer, Maki Sakuma, Heiko Mueller, Simon Wu, Imogen R Caldwell, Wolfgang Kern, Manja Meggendorfer, Claudia Haferlach, Torsten Haferlach
Journal: Blood
Blood (2022) 140 (Supplement 1): 3546–3547.
https://doi.org/10.1182/blood-2022-163300
Published: 2022